RESUMO
These studies probed the relationship between intrinsic efficacy and tolerance/cross-tolerance between ∆(9)-THC and synthetic cannabinoid drugs of abuse (SCBs) by examining in vivo effects and cellular changes concomitant with their repeated administration in mice. Dose-effect relationships for hypothermic effects were determined in order to confirm that SCBs JWH-018 and JWH-073 are higher efficacy agonists than ∆(9)-THC in mice. Separate groups of mice were treated with saline, sub-maximal hypothermic doses of JWH-018 or JWH-073 (3.0mg/kg or 10.0mg/kg, respectively) or a maximally hypothermic dose of 30.0mg/kg ∆(9)-THC once per day for 5 consecutive days while core temperature and locomotor activity were monitored via biotelemetry. Repeated administration of all drugs resulted in tolerance to hypothermic effects, but not locomotor effects, and this tolerance was still evident 14 days after the last drug administration. Further studies treated mice with 30.0mg/kg ∆(9)-THC once per day for 4 days, then tested with SCBs on day 5. Mice with a ∆(9)-THC history were cross-tolerant to both SCBs, and this cross-tolerance also persisted 14 days after testing. Select brain regions from chronically treated mice were examined for changes in CB1 receptor expression and function. Expression and function of hypothalamic CB1Rs were reduced in mice receiving chronic drugs, but cortical CB1R expression and function were not altered. Collectively, these data demonstrate that repeated ∆(9)-THC, JWH-018 and JWH-073 can induce long-lasting tolerance to some in vivo effects, which is likely mediated by region-specific downregulation and desensitization of CB1Rs.
Assuntos
Encéfalo/efeitos dos fármacos , Dronabinol/farmacologia , Tolerância a Medicamentos/fisiologia , Hipotermia/tratamento farmacológico , Indóis/farmacologia , Atividade Motora/efeitos dos fármacos , Naftalenos/farmacologia , Receptor CB1 de Canabinoide/metabolismo , Animais , Temperatura Corporal/efeitos dos fármacos , Encéfalo/metabolismo , Masculino , CamundongosRESUMO
Details are described of a simulated body shape utilized to determine patient dosimetry within whole body ultraviolet treatment cabinets. The body shape was designed to have a shape characteristic of the patient group undergoing treatment and was utilized in several Waldmann whole body treatment cabinets and with irradiance measurements undertaken using a Bentham DM150C spectroradiometer. It was considered that the rigid defined structure of the body shape allowed satisfactory reproducibility of measurements in such cabinets and also allowed additional parameters to be identified for evaluation of performance of such units.
Assuntos
Tamanho Corporal , Análise de Falha de Equipamento/instrumentação , Manequins , Terapia Ultravioleta/instrumentação , Contagem Corporal Total/instrumentação , Irradiação Corporal Total/instrumentação , Desenho de Equipamento , Análise de Falha de Equipamento/métodos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Terapia Ultravioleta/métodos , Contagem Corporal Total/métodos , Irradiação Corporal Total/métodosRESUMO
This paper presents the first outcome evaluation of multi-session groupwork for HIV prevention among gay men in the UK. This community-based RCT recruited 50 men, of whom 42% were HIV-positive or untested, and 32% reported status unknown or serodiscordant UAI in the previous 12 months. No knowledge, skills, attitudinal or behavioural differences were detected between intervention and control at baseline. At eight weeks, those attending the group reported significant gains over their control in making sexual choices, physical safety, HIV and STI transmission knowledge, and sexual negotiation skills. At 20 weeks, significant differences remained for HIV and STI transmission knowledge and comfort with sexual choices. Although no behavioural differences were detected, the aims of the National Prevention Strategy were met. This pilot RCT is appraised in the light of modest sample size and attrition, and recommendations for establishing behavioural outcomes are presented. This study has demonstrated that high-risk community samples can be recruited to multi-session interventions, and has provided feasibility data for future rigorous evaluation designs.
Assuntos
Infecções por HIV/prevenção & controle , Homossexualidade Masculina/psicologia , Adulto , Idoso , Grupos Focais/métodos , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Processos e Resultados em Cuidados de Saúde , Projetos Piloto , Assunção de Riscos , Comportamento SexualRESUMO
Solvent-detergent treatment, although used routinely in plasma product processing to inactivate enveloped viruses, substantially reduces product yield from the human plasma resource. To improve yields in plasma product manufacturing, a new viral reduction process has been developed using the fatty acid caprylate. As licensure of plasma products warrants thorough evaluation of pathogen reduction capabilities, the present study examined susceptibility of enveloped viruses to inactivation by caprylate in protein solutions with varied pH and temperature. In the immunoglobin-rich solutions from Cohn Fraction II+III, human immunodeficiency virus, Type-1, bovine viral diarrhea virus (BVDV), and pseudorabies virus were inactivated by caprylate concentrations of >/=9 mM, >/=12 mM, and >/=9 mM, respectively. Compared to solvent-detergent treatment, BVDV inactivation in Fraction II+III solution was significantly faster (20-60 fold) using 16 mM caprylate. Caprylate-mediated inactivation of BVDV was not noticeably affected by temperature within the range chosen manufacturing the immunoglobulin product. In Fraction II+III solutions, IgG solubility was unaffected by =19 mM caprylate. In albumin solution from Cohn supernatant IV-1, 40 mM caprylate rapidly inactivated BVDV, demonstrating versatility in inactivating enveloped viruses potentially present in other protein solutions. Our data show that caprylate is a robust enveloped virus inactivating agent for immunoglobulins and albumin which may potentially be utilized for other proteins; viral inactivation was not adversely affected by protein content and the buffer composition conditions evaluated. Within the parameters examined, caprylate inactivation of enveloped viruses provided comparable activity or advantages relative to the current, standard solvent-detergent treatment.
Assuntos
Caprilatos/farmacologia , Detergentes/farmacologia , Esterilização/métodos , Inativação de Vírus , Vírus/isolamento & purificação , Albuminas/metabolismo , Patógenos Transmitidos pelo Sangue , Cromatografia Gasosa , Cromatografia por Troca Iônica , HIV-1/isolamento & purificação , Concentração de Íons de Hidrogênio , Imunoglobulina A/sangue , Imunoglobulina A/metabolismo , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Cinética , Lipídeos/química , Nefelometria e Turbidimetria , Colato de Sódio/farmacologia , Solventes/farmacologia , Temperatura , Fatores de Tempo , Viroses/prevenção & controleRESUMO
A requirement for a minimal threshold level of moisture in order for efficient virus inactivation to occur during dry heat treatment of freeze-dried coagulation factor concentrates is described. Techniques used to determine moisture content during heating were Loss on Drying and Karl Fischer. The Loss on Drying was suspected to have occasional errors as a result of sample preparation being influenced by interference from atmospheric moisture. Therefore, a non-invasive, non-destructive method for determination of residual moisture content using near infrared spectrometry (NIR) was developed for freeze-dried antihaemophilic factor (AHF). Calibration equations were determined against Loss on Drying and Karl Fischer assay methods and these equations evaluated for the predictive efficiency. Both Loss on Drying and NIR were used to evaluate the effect of moisture content on the efficiency of virus inactivation by dry heat at 80 degrees C. A minimum level of moisture of greater than 0.7%, as determined by Loss on Drying, was necessary for a virus reduction in the magnitude of 4 log10 for hepatitis A virus, porcine parvovirus and pseudorabies virus.
Assuntos
Desinfecção/métodos , Fator VIII/efeitos adversos , Fator VIII/isolamento & purificação , Liofilização/métodos , Vírus/isolamento & purificação , Animais , Hepatovirus/isolamento & purificação , Herpesvirus Suídeo 1/isolamento & purificação , Temperatura Alta , Humanos , Parvoviridae/isolamento & purificação , Segurança , Espectroscopia de Luz Próxima ao Infravermelho , Suínos , Viroses/prevenção & controle , Viroses/transmissão , Vírus/patogenicidade , ÁguaRESUMO
BACKGROUND: Neuroblastoma rarely occurs in adults, and less than 10% of cases occur in patients older than 10 years. It has been suggested that the behavior of this disease may be different in older patients than in young children. The purpose of this study was to investigate the presentation, biologic features, and outcome of adolescent and adult patients with neuroblastoma to define differences from childhood neuroblastoma. METHODS: Medical record and pathology reviews were conducted for 16 patients age 13 years or older (13-33 years) at diagnosis who presented with neuroblastoma at the University of California-San Francisco (UCSF) during the period 1968-1995 (patients with intracerebral tumors, esthesioneuroblastoma, or ganglioneuroma were excluded). Six of these patients received their original diagnosis at UCSF, and the others were referred after diagnosis. The survival for the same period for all neuroblastoma patients ages 13-18 years (n = 38) registered in the Children's Cancer Group (CCG) was compared with the survival for those ages 1-13 years (n = 1912). Three of the UCSF patients were enrolled in CCG studies. RESULTS: Biologic characteristics observed in adolescents and adults differed from those observed in younger patients. In the UCSF population, only 6 of 15 tested patients age 13 or older had elevated urinary catecholamines, and 0 of 6 tested patients had MYCN amplification. There were two patients with Stage I disease, three with Stage II, two with Stage III, and nine with Stage IV. Primary sites were adrenal, pelvic, and retroperitoneal in four cases each; mediastinal in two cases; and paraspinal in two cases. Metastases in nine patients at diagnosis were observed in bone in five; in bone marrow in four; in lymph nodes in three; in the liver in two; and in the pleura, breast, and dura in one patient each. 131I-metaiodobenzylguanidine uptake was observed in 9 of 11 patients. Initial treatment included surgery for 13 of 16 patients, chemotherapy for 10 of 16, radiation therapy for 7 of 16, and autologous bone marrow transplantation for 1 of 16. Relapses occurred in 15 of 16 patients and death in 13 of 16, with overall survival 30% 5 years after diagnosis. Only 1 patient currently remains free of clinical disease 24 months after diagnosis. Several of these patients had long courses from diagnosis to death, with multiple recurrences and/or chronic, persistent disease. In the CCG data base, 76% of patients ages 13-18 years had metastatic disease at diagnosis. In this group, only 1 of 32 had MYCN amplification. The actuarial survival of all CCG patients ages 13-18 years was 7% at 5 years and 4% at 10 years, whereas that for patients ages 1-13 years was 30% at 5 years and 23% at 10 years. CONCLUSIONS: Neuroblastoma in adolescents and adults has different biologic characteristics and a longer course than in children; nevertheless, ultimately the outcome is poor regardless of stage. A much more aggressive or innovative therapeutic approach is needed for these patients.
Assuntos
Neuroblastoma/fisiopatologia , 3-Iodobenzilguanidina , Análise Atuarial , Adolescente , Adulto , Fatores Etários , Catecolaminas/urina , Criança , Pré-Escolar , Meios de Contraste , Intervalo Livre de Doença , Feminino , Amplificação de Genes , Genes myc/genética , Humanos , Lactente , Radioisótopos do Iodo , Iodobenzenos , Masculino , Recidiva Local de Neoplasia/patologia , Estadiamento de Neoplasias , Neuroblastoma/genética , Neuroblastoma/patologia , Neuroblastoma/secundário , Neuroblastoma/terapia , Compostos Radiofarmacêuticos , Estudos Retrospectivos , Taxa de Sobrevida , Resultado do TratamentoRESUMO
There are still no absolute tumour markers for cancers in most (if not all) tissues. Those markers that are available, other than those that physically detect a tumour, depend on organ-associated rather than tumour-specific proteins. Consequently, the likelihood of false positive or negative results is high. The ideal marker(s) should detect the presence of a tumour, its malignant potential, its stage in the progression pathway and the extent of spread. An added bonus would be for the marker to be organ-specific. Unfortunately, this paragon does not exist, but there are now experimental systems which can be exploited. Although all our requirements are not likely to be realized in the near future, some are within sight.
Assuntos
Neoplasias da Próstata/diagnóstico , Previsões , Testes Genéticos , Humanos , Masculino , Programas de Rastreamento/tendências , Neoplasias da Próstata/genética , Neoplasias da Próstata/prevenção & controleRESUMO
There are inner and outer gland groups in the human prostate. Benign nodular hyperplasia develops from the inner group of glands. Carcinomas arise in the outer glands and spread beyond the prostate at an early stage in the disease. The biological malignancy of prostatic cancer varies from patient to patient and from part to part of the same tumour. Some tumours remain biologically inactive or latent so that there must be some naturally occurring mechanism that controls tumour growth in some cases. This phenomenon is not confined to the prostate but can be found in many other organs, although not so frequently. It may represent a stage in tumour progression or reflect the balance between growth stimulating and inhibiting factors (Franks, 1956b). Our new knowledge of these factors suggests that this may be an area well worth looking at again. Prostatic cancer patients may be divided into groups that differ in their response to endocrine treatment. These differences may be due to changes in the tumour cells or in the host. A temporary state of tumour retardation or latency follows endocrine treatment in about 70-80% of all cases, but whatever form of treatment is used, about 75% of all patients die within 3 years. Even in tumours that show a marked response, endocrine treatment does not destroy all the tumour cells. Hormone sensitivity is not a property of the tumour as a whole but may vary from part to part of the same tumour.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Neoplasias da Próstata/terapia , Humanos , Masculino , Neoplasias da Próstata/patologiaRESUMO
The application of techniques for the transfer of genetic material between cells when used with recombinant DNA technologies and gene cloning procedures hold exciting possibilities for the genetic analysis of the metastatic behaviour of tumour cells. So far these genetic studies have produced confusing results, but some of the problems have been defined more clearly. For a more complete understanding of the metastatic phenotype a more critical analysis of the models used to mimic the process and a greater appreciation of the deficiencies in the techniques applied to study it are necessary.
Assuntos
Metástase Neoplásica/genética , Animais , Modelos Animais de Doenças/genética , Modelos Animais de Doenças/patologia , Humanos , FenótipoRESUMO
Transfection of the Ha-ras oncogene into a low metastatic epithelial cell line resulted in the acquirement of significantly increased metastatic capacity. This alteration in metastatic competence of a carcinoma line in a syngeneic system seemed to be a selective change and was not affected by parameters such as tumor latency period or local tumor growth. Transfection of the selection marker vectors with normal cellular DNA or with the N-ras gene did not lead to significantly increased metastatic capacity. Analysis of metastatic variants after oncogene transfection and in vivo selection showed integration of N-ras, but not of Ha-ras oncogenes. A possible role for the Ha-ras oncogene in the initial steps of metastasis will be discussed.
Assuntos
Regulação da Expressão Gênica , Metástase Neoplásica/genética , Oncogenes , Transfecção , Neoplasias da Bexiga Urinária/patologia , Animais , Linhagem Celular , Camundongos , Metástase Neoplásica/patologia , Neoplasias da Bexiga Urinária/genéticaAssuntos
Fundações/história , História da Medicina , Inglaterra , História do Século XX , Humanos , CuradoresRESUMO
Twenty-two continuous cell lines derived from normal and neoplastic urothelium, maintained under identical culture conditions, were characterized in terms of isozyme phenotype, tumorigenicity, and xenograft morphology following xenotransplantation to nude mice, cytological appearance, in vitro growth rate, labelling index, and colony-forming efficiency, in parallel with separate studies of in vitro drug sensitivities and monoclonal antibody reactivities. Three groups were identified: (a) distinct lines with differing isozyme patterns, a broad spectrum of growth characteristics, and xenograft morphologies similar to the histopathology of the parent tumors after periods of up to 17 yr following establishment in vitro; (b) cross-contaminated sublines (maintained separately in different laboratories for periods of up to 10 yr), with identical isozyme patterns and similar growth characteristics, but differing markedly in tumorigenicity and xenograft morphology; and (c) lines derived from normal urothelium which were nontumorigenic and had an isozyme pattern usually only encountered in untransformed cells. These data indicate that cell lines representative of human transitional cell carcinomas can be selected on the basis of xenograft morphology and isozyme patterns, and that a panel of lines derived from normal and neoplastic urothelium could provide a model system to study the biology and treatment of this disease.
Assuntos
Carcinoma de Células de Transição/patologia , Neoplasias da Bexiga Urinária/patologia , Carcinoma de Células de Transição/enzimologia , Ciclo Celular , Linhagem Celular , Sobrevivência Celular , Feminino , Humanos , Isoenzimas/análise , Masculino , Modelos Biológicos , Neoplasias da Bexiga Urinária/enzimologiaRESUMO
Somatic cell hybrids were produced by polyethylene glycol-induced cell fusion between metastatic CMT 167 (HGPRT-/OUAR) C57BL/Icrfat mouse lung carcinoma cells and 2 non-metastatic cell lines: C3H/He mouse L-M(TK-) cells of mesenchymal origin and EJ (OUAS) human bladder carcinoma cells. Fusion of 2 different CMT167 (HGPRT-) clones with L-M(TK-) cells followed by selection in HMT medium gave rise to 14 intraspecific hybrids, which were shown to express H-2 antigens specific for both the C57 and C3H mouse strains. Three interspecific hybrids arising from fusion of EJ(OUAS) and CMT167(HGPRT-/OUAR) cells were selected in HMT/ouabain medium and characterized by human isozyme analysis. All the hybrids produced large tumours after subcutaneous inoculation of 5 X 10(5) cells into adult athymic nu/nu mice. The intraspecific hybrid tumours were predominantly sarcomatous (mesenchymal) in structure but a few contained epithelial acini. Metastatic ability (as assessed by production of lung metastases) was completely suppressed in 13 of the 14 mouse/mouse hybrid cell clones. These results suggest that tumorigenicity, tumour structure and the ability to metastasize are expressed independently. The interspecific hybrids, which had not retained a full human chromosome complement, produced metastatic tumours that remained epithelial in structure.
Assuntos
Neoplasias Pulmonares/patologia , Metástase Neoplásica , Neoplasias Experimentais/patologia , Animais , Humanos , Células Híbridas/patologia , Neoplasias Pulmonares/genética , Camundongos , Neoplasias Experimentais/genética , FenótipoRESUMO
Total lactate dehydrogenase (LDH) activity and isoenzyme pattern were studied in tumour tissue from eight patients with maxillary adenocarcinoma, chronic inflammatory mucosa from 12 patients, normal maxillary mucosa from 12 patients, and an experimental lung adenocarcinoma and normal lung tissue from 12 mice. An increase in the total LDH activity and cathodic shift in LDH isoenzyme pattern was found in human maxillary adenocarcinoma as compared to normal and inflammatory mucosa. The inflammatory mucosa showed an increase in the total LDH activity and a normal isoenzyme pattern. The LDH alterations in the experimental lung adenocarcinoma in mice were similar to those in the human tumours but they were much more marked.
Assuntos
Adenocarcinoma/enzimologia , L-Lactato Desidrogenase/metabolismo , Neoplasias do Seio Maxilar/enzimologia , Neoplasias dos Seios Paranasais/enzimologia , Adulto , Idoso , Animais , Eletroforese em Acetato de Celulose , Humanos , Isoenzimas , Pulmão/enzimologia , Neoplasias Pulmonares/enzimologia , Seio Maxilar/enzimologia , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-IdadeRESUMO
Somatic cell hybrids have been made between a transformed mouse bladder carcinoma cell line and normal mouse bladder epithelium and mesenchyme. In the epithelial tumour/mesenchyme hybrids the malignant phenotype was expressed dominantly whereas in the carcinoma/normal epithelium hybrids the malignant potential was greatly reduced. In both cases the dominant in vitro and in vivo phenotype was that of the normal parental cells. All hybrid tumours were first palpable after 4-7 days, demonstrating that the tumours had not arisen as a result of in vivo selection of a sub-population of tumorigenic cells. Chromosome analysis showed that the carcinoma/normal epithelium hybrids were all in the hypertetraploid range but the large variation in the karyotypic profile of each hybrid made it impossible to implicate any specific chromosomes in the control of expression of the malignant phenotype. During normal development in bladder epithelium, terminal differentiation is associated with tetraploid formation by cell fusion. The reduction in malignancy of the carcinoma/normal epithelium hybrids may perhaps be due to the expression of genes associated with normal terminal differentiation after cell fusion and tetraploid formation. This is also supported by the more differentiated phenotype of the hybrid tumours. Of the 10 mesenchyme/epithelium hybrids analysed cytogenetically , four were in the hypertetraploid range from which little meaningful data could be obtained about specific chromosome losses. Chromosome analysis of the cells from the near-tetraploid hybrids showed only minor differences from what might have been expected from the input of the two parents; these differences appeared to be due to random chromosome loss. The maximum number of chromosomes lost from any of the hybrids was five, although one, two or three was more usual. The only consistent chromosome loss was of a single copy of chromosome 4, which in two of the hybrids represented the only chromosome change. The possibility that this loss might facilitate re-expression of the malignant phenotype is discussed.